Advanced search
Publication Cover
Journal of Medical Economics Volume 16, 2013 - Issue 8
Submit an article Journal homepage
2,237
Views
8
CrossRef citations to date
0
Altmetric
PSYCHIATRY: Original Articles

Annual cost of relapses and relapse-related hospitalizations in adults with schizophrenia: results from a 12-month, double-blind, comparative study of lurasidone vs quetiapine extended-release

Krithika RajagopalanSunovion Pharmaceuticals Inc. Marlborough, MAUSA
,
Ken O’DayXcenda Palm Harbor, FLUSACorrespondence[email protected]
,
Kellie MeyerXcenda Palm Harbor, FLUSA
,
Andrei PikalovSunovion Pharmaceuticals Inc. Marlborough, MAUSA
&
Antony LoebelSunovion Pharmaceuticals Inc. Marlborough, MAUSA
Pages 987-996 | Accepted 24 May 2013, Published online: 21 Jun 2013

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Michael L. Ganz, Ameya Chavan, Rahul Dhanda, Michael Serbin & Charles Yonan. (2021) Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. Journal of Medical Economics 24:1, pages 103-113.
Read now
Leslie Citrome. (2016) Schizophrenia relapse, patient considerations, and potential role of lurasidone. Patient Preference and Adherence 10, pages 1529-1537.
Read now

Articles from other publishers (6)

Umberto Restelli, Manuel García-Goñi, Michal Lew-Starowicz, Pawel Mierzejewski, Sofia Silvola, Jacqueline Mayoral-van Son, Davide Croce, Paola Rocca & Benedicto Crespo-Facorro. (2020) Cost of Relapse Management in Patients with Schizophrenia in Italy and Spain: Comparison Between Lurasidone and Quetiapine XR. Clinical Drug Investigation 40:9, pages 861-871.
Crossref
Laura Rosero Parra, Lizeth Guerrero Pantoja, Natali Lorena Mena, Fiderman Machuca-Martínez & Julian Urresta. (2020) Evaluation of TiO2 and SnO Supported on Graphene Oxide (TiO2-GO and SnO-GO) Photocatalysts for Treatment of Hospital Wastewater. Water 12:5, pages 1438.
Crossref
Dawn Velligan, William Carpenter, Heidi C. Waters, Nicole M. Gerlanc, Susan N. Legacy & Charles Ruetsch. (2018) Relapse Risk Assessment for Schizophrenia Patients (RASP): A New Self-Report Screening Tool. Clinical Schizophrenia & Related Psychoses 11:4, pages 224-235.
Crossref
Mônica Kayo & Denise Razzouk. 2017. Mental Health Economics. Mental Health Economics 313 322 .
Mikayla J. Klug, April N. Smith & Paul L. Price. (2014) A retrospective analysis of inpatient utilization of paliperidone palmitate and readmission rates. Mental Health Clinician 4:5, pages 260-263.
Crossref
Jinguo Zhai, Xiaofeng Guo, Min Chen, Jingping Zhao & Zhonghua Su. (2013) An investigation of economic costs of schizophrenia in two areas of China. International Journal of Mental Health Systems 7:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.